Back to Search Start Over

Ferulic acid promoting apoptosis in human osteosarcoma cell lines.

Authors :
Zhang XD
Wu Q
Yang SH
Source :
Pakistan journal of medical sciences [Pak J Med Sci] 2017 Jan-Feb; Vol. 33 (1), pp. 127-131.
Publication Year :
2017

Abstract

Objective: To explore the promoting apoptosis and antitumor activities of ferulic acid (FA) in human osteosarcoma and its potential mechanism.<br />Methods: The SaOS-2 and MG63 osteosarcoma cell lines were opted to experiment and these cells were, respectively, cultured with various concentrations of FA (0 μM, 10 μM, 20 μM, 40 μM) for 72 hours at 37°C. The viabilities of the FA treated cells were monitored by MTT. Apoptosis cells were evaluated using annexin V/PI by flow cytometry. Apoptosis proteins caspase-3, procaspase-3, Bcl-2 and Bax were detected by western blot. Expressions of apoptotic genes Bcl-2 and Bax were quantified by qPCR.<br />Results: The cell viabilities were critically declined in the concentration-dependent manner in FA groups ( P < 0.01). The apoptosis cells were increased proportionately with the concentration of FA ( P < 0.05). The procaspase-3 protein contents, and Bcl-2 mRNA and protein contents were significantly decreased while caspase-3 protein contents, and Bax mRNA and protein contents were concomitantly increased in the concentration-dependent manner in FA groups ( P < 0.05). The response to FA by the SaOS-2 osteosarcoma cell was similar with the MG63 osteosarcoma cell ( P > 0.05).<br />Conclusion: Ferulic acid could significantly descend osteosarcoma cell viability through the promoting apoptosis pathway in which FA activates both caspase-3 and Bax and inactivates Bcl-2.<br />Competing Interests: Declaration of interest: The authors have no conflict of interest regarding any part in this article.

Details

Language :
English
ISSN :
1682-024X
Volume :
33
Issue :
1
Database :
MEDLINE
Journal :
Pakistan journal of medical sciences
Publication Type :
Academic Journal
Accession number :
28367185
Full Text :
https://doi.org/10.12669/pjms.331.12066